The future of Accountable Care Organizations is very much undefined, as an ACO right now isn’t working to its full potential. However, Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American, is positive that the healthcare system will get there in the coming years.
The future of accountable care organizations (ACO) is very much undefined, as an ACO right now isn’t working to its full potential. However, Joe Antos, PhD, the Wilson H. Taylor Scholar in Health Care and Retirement Policy at the American, is positive that the healthcare system will get there in the coming years.
Transcript (slightly modified)
With Medicare shifting to alternative payment models, but fee-for-service still very much alive, how do payers and providers reconcile these 2 payment models?
Well, alternative payment models are primarily in the eye of the beholder. Certainly, we know what an ACO is because ACOs have been around now for several years. What we don’t know is what will an ACO be in the next few years. Under the next administration, again Democrat or Republican, I see some changes in the way it’s operated to make it a much more effective and practical program. I think that’s good.
Bundled payment — that’s another form of alternative payment model but in fact, there’s really only one bundled payment project now going. It’s for hip and knee replacement and in fact, it’s very, very difficult to construct sensible bundled payments for really almost anything. It’s very, very difficult. So I don’t see bundled payments going very far but I think a lot of work will be put into them.
In the end, I don’t think that’s where we’re going to go. Instead, we need more organized systems of delivery. That’s what ACO’s are supposed to be. Although, I think they fall short of that. That’s what Medicare Advantage plans are supposed to be — they fall short of that as well. The traditional Medicare program doesn’t pretend that it’s an organized system of care but we’re going to get there.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More